CSIMarket
 


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's Operating Income Growth by Quarter and Year

Laboratory Of America Holdings's Operating Income results by quarter and year




LH Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -134.00 90.70 730.60 1,293.20
III Quarter September 252.30 469.40 766.90 1,047.10
II Quarter June 266.30 525.90 704.10 297.70
I Quarter March 341.00 687.90 1,057.90 -192.60
FY   725.60 1,773.90 3,259.50 2,445.40



LH Operating Income fourth quarter 2023 Y/Y Growth Comment
Laboratory Corporation Of America Holdings in the fourth quarter 2023 recorded Operating Loss of $ -134.00 millions.

Looking into fourth quarter 2023 results within Medical Laboratories industry 4 other companies have achieved higher Operating Income growth. While Laboratory Corporation Of America Holdings' s Operating Income no change of % ranks overall at the positon no. 893 in the fourth quarter 2023.

Explain Operating Income growth


LH Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -87.59 % -43.5 % 284.42 %
III Quarter September -46.25 % -38.79 % -26.76 % 208.06 %
II Quarter June -49.36 % -25.31 % 136.51 % -11.32 %
I Quarter March -50.43 % -34.97 % - -
FY   -59.1 % -45.58 % 33.29 % 83.84 %

Financial Statements
Laboratory Of America Holdings's fourth quarter 2023 Operating Income $ -134.00 millions LH's Income Statement
Laboratory Of America Holdings's fourth quarter 2022 Operating Income $ 90.70 millions Quarterly LH's Income Statement
New: More LH's historic Operating Income Growth >>


LH Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -80.68 % -4.73 % 23.5 %
III Quarter September -5.26 % -10.74 % 8.92 % 251.73 %
II Quarter June -21.91 % -23.55 % -33.44 % -
I Quarter March 275.96 % -5.84 % -18.2 % -
FY (Year on Year)   -59.1 % -45.58 % 33.29 % 83.84 %




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #68
Overall #893

Operating Income Y/Y Growth Statistics
High Average Low
424.99 % 14.64 % -77.59 %
(Jun 30 2021)   (Dec 31 2013)
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #5
Healthcare Sector #68
Overall #893
Operating Income Y/Y Growth Statistics
High Average Low
424.99 % 14.64 % -77.59 %
(Jun 30 2021)   (Dec 31 2013)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Laboratory Of America Holdings's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LH's IV. Quarter Q/Q Operating Income Comment
Recent results of -134.00 millions by Laboratory Corporation Of America Holdings come out even less good considering the 252.30 millions in the third quarter.

Within Medical Laboratories industry Laboratory Corporation Of America Holdings achieved highest sequential Operating Income growth. While Laboratory Of America Holdings's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LH's IV. Quarter Q/Q Operating Income Comment
Current Operating Loss of -134.00 millions by Laboratory Corporation Of America Holdings come out even more unfavourable compare to the Operating Loss 252.30 millions in the previous quarter.

Within Medical Laboratories industry Laboratory Corporation Of America Holdings achieved highest sequential Operating Income growth. While Laboratory Of America Holdings's Operating Income growth quarter on quarter, overall rank is .


Laboratory Of America Holdings's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Operating Income 12 Months Ending $ 725.60 $ 950.30 $ 1,773.90 $ 2,413.80 $ 2,711.30
Y / Y Operating Income Growth (TTM) -59.1 % -60.63 % -45.58 % -36.85 % -33.91 %
Year on Year Operating Income Growth Overall Ranking # 1203 # 326 # 594 # 526 # 468
Seqeuential Operating Income Change (TTM) -23.65 % -18.6 % -26.51 % -10.97 % -6.17 %
Seq. Operating Income Growth (TTM) Overall Ranking # 893 # 287 # 1375 # 1338 # 1290




Cumulative Operating Income growth Comment
Laboratory Of America Holdings showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Laboratory Of America Holdings's annual Operating Income decline would be -59.1% year on year to $726 millions.

In the Healthcare sector 90 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 326 to 1203.

Operating Income TTM Q/Q Growth Statistics
High Average Low
424.99 %
14.64 %
-77.59 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 91
Overall # 1203

Operating Income TTM Y/Y Growth Statistics
High Average Low
424.99 %
14.64 %
-77.59 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 68
S&P 500 # 893
Cumulative Operating Income growth Comment
Laboratory Of America Holdings showed decline, but improvement compare to trailing twelve month Operating Income decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Laboratory Of America Holdings's annual Operating Income drop would be -59.1% year on year to $726 millions.

In the Healthcare sector 90 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 326 to 1203.

Operating Income TTM Q/Q Growth Statistics
High Average Low
424.99 %
14.64 %
-77.59 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 5
Healthcare Sector # 91
Overall # 1203

Operating Income TTM Y/Y Growth Statistics
High Average Low
424.99 %
14.64 %
-77.59 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 68
S&P 500 # 893




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
LH's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for LH's Competitors
Operating Income Growth for Laboratory Of America Holdings's Suppliers
Operating Income Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Cadre Holdings Inc -0.36%$ -0.362 millions
Prestige Consumer Healthcare Inc -0.40%$ -0.404 millions
Phibro Animal Health Corporation-0.90%$ -0.903 millions
Inmode Ltd -1.11%$ -1.109 millions
Resmed Inc -1.82%$ -1.820 millions
Essa Pharma inc -3.45%$ -3.446 millions
Bausch and Lomb Corp-3.92%$ -3.922 millions
National Research Corporation-4.35%$ -4.346 millions
Vertex Pharmaceuticals Inc-4.35%$ -4.354 millions
Icecure Medical Ltd -6.95%$ -6.948 millions
Fresenius Medical Care Ag-9.41%$ -9.414 millions
Edwards Lifesciences Corporation-10.65%$ -10.652 millions
Regeneron Pharmaceuticals Inc -15.16%$ -15.164 millions
Harmony Biosciences Holdings inc -15.58%$ -15.578 millions
Scisparc Ltd -17.76%$ -17.763 millions
Charles River Laboratories International inc -18.86%$ -18.856 millions
Biogen Inc -19.42%$ -19.417 millions
Mettler toledo International Inc -19.91%$ -19.915 millions
Bristol myers Squibb Company-20.65%$ -20.646 millions
Qiagen N v -22.87%$ -22.866 millions
Baxter International Inc -22.95%$ -22.946 millions
Artivion Inc -23.20%$ -23.196 millions
Bio rad Laboratories Inc -24.46%$ -24.460 millions
Hologic Inc-24.47%$ -24.466 millions
Becton Dickinson And Company-24.96%$ -24.957 millions
Mesoblast Ltd-25.69%$ -25.686 millions
Sanofi-26.10%$ -26.098 millions
Amedisys Inc -26.45%$ -26.448 millions
Avantor Inc -27.20%$ -27.204 millions
Gilead Sciences Inc -28.89%$ -28.893 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com